Cinven Makes Strategic Investment in Regenity Biosciences (Linden Capital Partners)
February 12, 2026
Cinven has agreed to make a strategic investment in Regenity Biosciences, a Linden Capital Partners portfolio company. The investment creates a partnership between Cinven and Regenity’s management to support growth and expand Regenity’s innovation and commercialization efforts across its regenerative bioresorbable technologies.
- Buyers
- Cinven
- Targets
- Regenity Biosciences
- Platforms
- Linden Capital Partners
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.